EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis

Shaohua Li iD, Qiang Lyu, Qixin Shi, Yungang Bai, Xinling Ren, Jin Ma iD

Clinical Science · 2024

DOI: 10.1042/cs20231508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Shaohua Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aerospace Physiology, Air Force Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Altitude Sickness, Hypertension, Pulmonary. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Air Force Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-altitude pulmonary hypertension (HAPH) is a severe and progressive disease that can lead to right heart failure. Intermittent short-duration reoxygenation at high altitude is effective in alleviating HAPH; however, the underlying mechanisms are unclear. In the present study, a simulated 5,000-m hypoxia rat model and hypoxic cultured pulmonary artery smooth muscle cells (PASMCs) were used to evaluate the effect and mechanisms of intermittent short-duration reoxygenation. The results showed that intermittent 3-h/per day reoxygenation (I3) effectively attenuated chronic hypoxia-induced pulmonary hypertension and reduced the content of H2O2 and the expression of NADPH oxidase 4 (NOX4) in lung tissues. In combination with I3, while the NOX inhibitor apocynin did not further alleviate HAPH, the mitochondrial antioxidant MitoQ did. Furthermore, in PASMCs, I3 attenuated hypoxia-induced PASMCs proliferation and reversed the activated HIF-1α/NOX4/PPAR-γ axis under hypoxia. Targeting this axis offset the protective effect of I3 on hypoxia-induced PASMCs proliferation. The present study is novel in revealing a new mechanism for preventing HAPH and provides insights into the optimization of intermittent short-duration reoxygenation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Altitude SicknessHypertension, PulmonaryAnimalsRatsAltitudeCell ProliferationCells, CulturedHydrogen PeroxideHypoxiaMyocytes, Smooth MuscleNADPH Oxidase 4PPAR gammaPulmonary ArterySignal Transduction

Stichwörter der Autor:innen

NADHP oxidase 4hypobaric hypoxiaintermittent short-duration reoxygenationpulmonary hypertension

Substanzen

Hydrogen PeroxideNADPH Oxidase 4PPAR gammaNox4 protein, rat

Autor:innen und Institutionen

  • Department of Aerospace Physiology, Air Force Medical University, Xi'an 710032, China.
  • Department of Nephrology, Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China.
  • Department of Respiratory and Critical Care Medicine, Shenzhen University General Hospital, Shenzhen 518071, China.

ORCID-Profile: Shaohua Li, Jin Ma

Förderung

  • National Natural Science Foundation of China
  • Air Force Medical University

Zitieren

APA

Li, S., Lyu, Q., Shi, Q., Bai, Y., Ren, X., & Ma, J. (2024). Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis. Clinical Science. https://doi.org/10.1042/cs20231508

Vancouver

Li S, Lyu Q, Shi Q, Bai Y, Ren X, Ma J. Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis. Clinical Science. 2024. doi:10.1042/cs20231508

BibTeX
@article{Li2024,
  author = {Li, Shaohua and Lyu, Qiang and Shi, Qixin and Bai, Yungang and Ren, Xinling and Ma, Jin},
  title = {Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis},
  journal = {Clinical Science},
  year = {2024},
  doi = {10.1042/cs20231508}
}
Kostenlos starten →